Anti-gonadotrophin releasing hormone vaccine - Aphton/GSK
Alternative Names: GnRH immunogen; GnRH pharmaccine; Gonadimmune™Latest Information Update: 02 Jul 2023
Price :
$50 *
At a glance
- Originator Aphton Corporation
- Developer Aphton Corporation; GSK
- Class Antiandrogens; Antiprogestogens; Vaccines
- Mechanism of Action Estrogen receptor antagonists; Gonadotropin releasing hormone inhibitors; Immunostimulants; Progesterone receptor antagonists; Testosterone antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Breast cancer; Endometrial cancer; Endometriosis; Prostate cancer
Most Recent Events
- 07 Jun 2006 Discontinued - Phase-II for Prostate cancer in Europe (IM)
- 07 Jun 2006 Discontinued - Phase-II for Prostate cancer in USA (IM)
- 07 Jun 2006 Discontinued - Preclinical for Breast cancer in USA (IM)